申请人:SMITH KLINE & FRENCH LABORATORIES
LIMITED
公开号:EP0246774A1
公开(公告)日:1987-11-25
Compounds of structure (I)
in which, R1 to R4 are the same or different and are each hydrogen, halogen, trifluoromethyl, C1-6alkyl, C1-6alkoxy, C1-6alkanoyl, C1-6alkoxycarbonyl, RCF20, an ethoxy group substituted by 3 to 5 fluorine atoms, or R2 and R3 together form a group -O(CR2)mO-; R is hydrogen or fluorine; m is 1 or 2; n is 0 or 1; R5 and R6 are the same or different and are each hydrogen, C1-6alkyl or C3-6cycloalkyl or R5 and R6 together with the nitrogen atom to which they are attached form an azetidino, pyrrolidino, piperidino, piperazino, N-C1- 4alkylpiperazino or morpholino group; and one of R7 and R8 is fluorine, and the other is hydrogen, fluorine or C1-6alkyl; processes and intermediates for their preparation, formulations containing them and their use in therapy for the inhibition of exogenously and endogenously stimulated gastric acid secretion.
结构(I)的化合物
其中,R1 至 R4 相同或不同,各自为氢、卤素、三氟甲基、C1-6烷基、C1-6烷氧基、C1-6烷酰基、C1-6烷氧羰基、RCF20、被 3 至 5 个氟原子取代的乙氧基,或 R2 和 R3 共同形成一个基团-O(CR2)mO-;R 为氢或氟;m 为 1 或 2;n 为 0 或 1;R5 和 R6 相同或不同,各自为氢、C1-6 烷基或 C3-6 环烷基,或 R5 和 R6 与它们所连接的氮原子一起形成叠氮基、吡咯烷基、哌啶基、哌嗪基、N-C1- 4 烷基哌嗪基或吗啉基;R7和R8中的一个是氟,另一个是氢、氟或C1-6烷基;制备它们的工艺和中间体、含有它们的制剂以及它们在治疗中用于抑制外源性和内源性刺激的胃酸分泌。